The International Organization for Standardization (ISO) has released multiple updated standards for medical devices, IVDs, and healthcare systems in 2025 and 2026.
This article provides a comprehensive list of key ISO standards relevant to medical device manufacturers, quality professionals, and regulatory affairs teams.
| Top Medical Device Standards (Recently Published or Reviewed) | |||
| Sno. | Standard | Title | Published/Reviewed |
| 1 | ISO 14155 | Clinical investigation of medical devices for human subjects — Good clinical practice | 2026 |
| 2 | ISO 20417 | Medical devices — Information to be supplied by the manufacturer | 2026 |
| 3 | ISO 10993-1 | Biological evaluation of medical devices — Part 1: Requirements and general principles | 2025 |
| 4 | ISO 80601-2-61 | Medical electrical equipment — Part 2-61: Pulse oximeter equipment | 2026 |
| 5 | ISO 80601-2-74 | Medical electrical equipment — Part 2-74: Respiratory humidifying equipment | 2026 |
| 6 | ISO 15223-1 | Medical devices — Symbols to be used with information supplied by the manufacturer | 2021 (Reviewed) |
| 7 | ISO 13485 | Medical devices — Quality management systems — Requirements for regulatory purposes | 2025 |
| 8 | ISO 14971 | Medical devices — Application of risk management | 2025 |
| 9 | ISO 22367 | Medical laboratories — Application of risk management to medical laboratories | 2026 |
| 10 | ISO 80601-2-69 | Medical electrical equipment — Part 2-69: Oxygen concentrator equipment | 2026 |
| 11 | IEC 62366-1 | Medical devices — Part 1: Application of usability engineering | 2021 |
| 12 | IEC 62304 | Medical device software — Software life cycle processes | 2021 |
| 13 | ISO 15189 | Medical laboratories — Requirements for quality and competence | 2022 |
| 14 | ISO 7101 | Healthcare organization management — Management systems for quality in healthcare organizations | 2023 |
| Biological Evaluation & Biocompatibility Standards | |||
| 15 | ISO 10993-12 | Biological evaluation of medical devices — Part 12: Sample preparation and reference materials | 2021 |
| 16 | ISO 10993-17 | Biological evaluation of medical devices — Part 17: Toxicological risk assessment | 2023 |
| 17 | ISO 10993-18 | Biological evaluation of medical devices — Part 18: Chemical characterization | 2025 |
| 18 | ISO 10993-23 | Biological evaluation of medical devices — Part 23: Tests for irritation | 2021 |
| 19 | ISO 10993-4 | Biological evaluation of medical devices — Part 4: Tests for interactions with blood | 2017 |
| 20 | ISO 10993-10 | Biological evaluation of medical devices — Part 10: Tests for skin sensitization | 2021 |
| 21 | ISO 10993-5 | Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity | 2022 |
| 22 | ISO 10993-11 | Biological evaluation of medical devices — Part 11: Tests for systemic toxicity | 2017 |
| 23 | ISO 10993-7 | Biological evaluation of medical devices — Part 7: Ethylene oxide sterilization residuals | 2008 |
| 24 | ISO 10993-3 | Biological evaluation of medical devices — Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity | 2014 |
| 25 | ISO 10993-6 | Biological evaluation of medical devices — Part 6: Tests for local effects after implantation | 2016 |
| 26 | ISO/TR 24971 | Medical devices — Guidance on the application of ISO 14971 | 2020 |
| Sterilization Standards | |||
| 27 | ISO 11135 | Sterilization of health-care products — Ethylene oxide | 2014 |
| 28 | ISO 11137-1 | Sterilization of health care products — Radiation — Part 1: Requirements | 2025 |
| 29 | ISO 17665 | Sterilization of health care products — Moist heat | 2024 |
| 30 | ISO 11607-1 | Packaging for terminally sterilized medical devices — Part 1: Requirements | 2024 |
| 31 | ISO 11607-2 | Packaging for terminally sterilized medical devices — Part 2: Validation requirements | 2024 |
| 32 | ISO 11737-1 | Sterilization of health care products — Microbiological methods — Part 1: Population of microorganisms | 2018 |
| 33 | ISO 11737-2 | Sterilization of health care products — Microbiological methods — Part 2: Tests of sterility | 2025 |
| 34 | ISO 11737-3 | Sterilization of health care products — Microbiological methods — Part 3: Bacterial endotoxin testing | 2023 |
| 35 | ISO 14937 | Sterilization of health care products — General requirements for characterization of a sterilizing agent | 2009 |
| 36 | ISO 22441 | Sterilization of health care products — Low temperature vaporized hydrogen peroxide | 2022 |
| 37 | ISO 11138-1 | Sterilization of health care products — Biological indicators — Part 1: General requirements | 2022 |
| 38 | ISO 11140-1 | Sterilization of health care products — Chemical indicators — Part 1: General requirements | 2014 |
| Cleanrooms & Controlled Environments | |||
| 39 | ISO 14644-1 | Cleanrooms and associated controlled environments — Part 1: Classification of air cleanliness | 2021 |
| 40 | ISO 14644-2 | Cleanrooms and associated controlled environments — Part 2: Monitoring to provide evidence of cleanroom performance | 2021 |
| 41 | ISO 14644-3 | Cleanrooms and associated controlled environments — Part 3: Test methods | 2019 |
| 42 | ISO 14644-4 | Cleanrooms and associated controlled environments — Part 4: Design, construction and start-up | 2022 |
| 43 | ISO 14644-5 | Cleanrooms and associated controlled environments — Part 5: Operations | 2025 |
| 44 | ISO 14644-7 | Cleanrooms and associated controlled environments — Part 7: Separative devices | 2004 |
| 45 | ISO 14644-8 | Cleanrooms and associated controlled environments — Part 8: Assessment of air cleanliness by chemical concentration | 2022 |
| 46 | ISO 14644-9 | Cleanrooms and associated controlled environments — Part 9: Assessment of surface cleanliness for particle concentration | 2022 |
| 47 | ISO 14644-10 | Cleanrooms and associated controlled environments — Part 10: Assessment of surface cleanliness for chemical contamination | 2022 |
| 48 | ISO 14644-12 | Cleanrooms and associated controlled environments — Part 12: Specifications for monitoring air cleanliness | 2018 |
| 49 | ISO 14644-13 | Cleanrooms and associated controlled environments — Part 13: Cleaning of surfaces to achieve defined levels of cleanliness | 2026 |
| 50 | ISO 14644-14 | Cleanrooms and associated controlled environments — Part 14: Assessment of suitability for use of equipment | 2026 |
| 51 | ISO 14644-15 | Cleanrooms and associated controlled environments — Part 15: Assessment of suitability for use of equipment | 2017 |
| 52 | ISO 14644-16 | Cleanrooms and associated controlled environments — Part 16: Energy efficiency in cleanrooms | 2019 |
| 53 | ISO 14644-17 | Cleanrooms and associated controlled environments — Part 17: Particle deposition rate applications | 2021 |
| 54 | ISO 14644-18 | Cleanrooms and associated controlled environments — Part 18: Assessment of suitability of consumables | 2023 |
| Software & Digital Health Standards | |||
| 55 | IEC 62304 | Medical device software — Software life cycle processes | 2021 |
| 56 | IEC 62366-1 | Medical devices — Part 1: Application of usability engineering | 2021 |
| 57 | IEC/TR 62366-2 | Medical devices — Part 2: Guidance on the application of usability engineering | 2016 |
| 58 | IEC 81001-5-1 | Health software and health IT systems safety, effectiveness and security — Part 5-1: Security — Activities in the product life cycle | 2021 |
| 59 | IEC 82304-1 | Health software — Part 1: General requirements for product safety | 2021 |
| 60 | ISO/IEC 29138-1 | Information technology — User interface accessibility — Part 1: User accessibility needs | 2024 |
| 61 | ISO 27799 | Health informatics — Information security management in health using ISO/IEC 27002 | 2025 |
| 62 | ISO 81001-1 | Health software and health IT systems safety, effectiveness and security — Part 1: Principles and concepts | 2021 |
| 63 | IEC 80001-1 | Application of risk management for IT-networks incorporating medical devices — Part 1: Safety, effectiveness and security | 2021 |
| In Vitro Diagnostic (IVD) Standards | |||
| 64 | ISO 15189 | Medical laboratories — Requirements for quality and competence | 2022 |
| 65 | ISO 22367 | Medical laboratories — Application of risk management to medical laboratories | 2026 |
| 66 | ISO 23640 | In vitro diagnostic medical devices — Evaluation of stability of in vitro diagnostic reagents | 2011 |
| 67 | ISO 17511 | In vitro diagnostic medical devices — Requirements for establishing metrological traceability | 2026 |
| 68 | ISO 20916 | In vitro diagnostic medical devices — Clinical performance studies using specimens from human subjects — Good study practice | 2025 |
| 69 | ISO 5649 | Medical laboratories — Concepts and specifications for the design, development, implementation and use of laboratory-developed tests | 2024 |
| 70 | ISO 20387 | Biotechnology — Biobanking — General requirements for biobanking | 2018 |
| 71 | ISO 20395 | Biotechnology — Requirements for evaluating the performance of quantification methods for nucleic acid target sequences — qPCR and dPCR | 2019 |
| 72 | CLSI EP Series | IVD performance evaluation standards | Various dates |
| Medical Electrical Equipment (IEC 60601 Series) | |||
| 73 | IEC 60601-1-8 | Medical electrical equipment — Part 1-8: General requirements for basic safety and essential performance — Collateral standard: Alarm systems | 2006 |
| 74 | IEC 60601-1-11 | Medical electrical equipment — Part 1-11: General requirements for basic safety and essential performance — Collateral standard: Home healthcare environment | 2025 |
| 75 | IEC 60601-1-12 | Medical electrical equipment — Part 1-12: General requirements for basic safety and essential performance — Collateral standard: Emergency medical services environment | 2014 |
| 76 | IEC 80601-2-61 | Medical electrical equipment — Part 2-61: Particular requirements for basic safety and essential performance of pulse oximeter equipment | 2026 |
| 77 | IEC 80601-2-69 | Medical electrical equipment — Part 2-69: Particular requirements for the basic safety and essential performance of oxygen concentrator equipment | 2026 |
| 78 | IEC 80601-2-74 | Medical electrical equipment — Part 2-74: Particular requirements for basic safety and essential performance of respiratory humidifying equipment | 2026 |
| 79 | IEC 80601-2-49 | Medical electrical equipment — Part 2-49: Particular requirements for the basic safety and essential performance of multifunction patient monitoring equipment | 2018 |
| 80 | IEC 80601-2-77 | Medical electrical equipment — Part 2-77: Particular requirements for the basic safety and essential performance of robotically assisted surgical equipment | 2019 |
| 81 | IEC 80601-2-78 | Medical electrical equipment — Part 2-78: Particular requirements for basic safety and essential performance of medical robots for rehabilitation | 2019 |
| 82 | IEC 80601-2-89 | Medical electrical equipment — Part 2-89: Particular requirements for the basic safety and essential performance of medical beds for children | 2025 |
| Labelling & Symbols Standards | |||
| 83 | ISO 20417 | Medical devices — Information to be supplied by the manufacturer | 2026 |
| 84 | ISO 15223-1 | Medical devices — Symbols to be used with information to be supplied by the manufacturer — Part 1: General requirements | 2021 |
| 85 | ISO 15223-2 | Medical devices — Symbols to be used with medical device labels, labelling, and information to be supplied — Part 2: Symbol development, selection and validation | 2010 |
| 86 | ISO 18113-1 | In vitro diagnostic medical devices — Information supplied by the manufacturer (labelling) — Part 1: Terms, definitions, and general requirements | 2022 |
| 87 | ISO 18113-2 | In vitro diagnostic medical devices — Information supplied by the manufacturer (labelling) — Part 2: In vitro diagnostic reagents for professional use | 2022 |
| 88 | ISO 18113-3 | In vitro diagnostic medical devices — Information supplied by the manufacturer (labelling) — Part 3: In vitro diagnostic instruments for professional use | 2022 |
| 89 | ISO 18113-4 | In vitro diagnostic medical devices — Information supplied by the manufacturer (labelling) — Part 4: In vitro diagnostic reagents for self-testing | 2022 |
| 90 | ISO 18113-5 | In vitro diagnostic medical devices — Information supplied by the manufacturer (labelling) — Part 5: In vitro diagnostic instruments for self-testing | 2022 |
| Quality Management & Risk Management Standards | |||
| 91 | ISO 13485 | Medical devices — Quality management systems — Requirements for regulatory purposes | 2025 |
| 92 | ISO 14971 | Medical devices — Application of risk management to medical devices | 2025 |
| 93 | ISO/TR 24971 | Medical devices — Guidance on the application of ISO 14971 | 2020 |
| 94 | ISO 15378 | Primary packaging materials for medicinal products — Particular requirements for the application of ISO 9001:2015, with reference to good manufacturing practice (GMP) | 2023 |
| 95 | ISO 7101 | Healthcare organization management — Management systems for quality in healthcare organizations — Requirements | 2023 |
| 96 | ISO 35001 | Biorisk management for laboratories and other related organisations | 2019 |
| Implants & Surgical Devices Standards | |||
| 97 | ISO 14630 | Non-active surgical implants — General requirements | 2024 |
| 98 | ISO 5832-1 | Implants for surgery — Metallic materials — Part 1: Wrought stainless steel | 2024 |
| 99 | ISO 5832-2 | Implants for surgery — Metallic materials — Part 2: Unalloyed titanium | 2025 |
| 100 | ISO 5832-3 | Implants for surgery — Metallic materials — Part 3: Wrought titanium 6-aluminium 4-vanadium alloy | 2021 |
| 101 | ISO 5832-4 | Implants for surgery — Metallic materials — Part 4: Cobalt-chromium-molybdenum casting alloy | 2024 |
| 102 | ISO 5832-5 | Implants for surgery — Metallic materials — Part 5: Wrought cobalt-chromium-tungsten-nickel | 2022 |
| 103 | ISO 5832-6 | Implants for surgery — Metallic materials — Part 6: Wrought cobalt-nickel-chromium-molybdenum alloy | 2022 |
| 104 | ISO 5832-11 | Implants for surgery — Metallic materials — Part 11: Wrought titanium 6-aluminium 7-niobium alloy | 2024 |
| 105 | ISO 5832-12 | Implants for surgery — Metallic materials — Part 12: Wrought cobalt-chromium-molybdenum alloy | 2019 |
| 106 | ISO 5834-1 | Implants for surgery — Ultra-high-molecular-weight polyethylene — Part 1: Powder form | 2025 |
| 107 | ISO 5834-2 | Implants for surgery — Ultra-high-molecular-weight polyethylene — Part 2: Moulded forms | 2025 |
| 108 | ISO 5834-3 | Implants for surgery — Ultra-high-molecular-weight polyethylene — Part 3: Accelerated ageing methods | 2025 |
| 109 | ISO 5834-4 | Implants for surgery — Ultra-high-molecular-weight polyethylene — Part 4: Oxidation index measurement method | 2025 |
| 110 | ISO 5834-5 | Implants for surgery — Ultra-high-molecular-weight polyethylene — Part 5: Morphology assessment method | 2025 |
| 111 | ISO 5840-1 | Cardiovascular implants — Cardiac valve prostheses — Part 1: General requirements | 2021 |
| 112 | ISO 5840-2 | Cardiovascular implants — Cardiac valve prostheses — Part 2: Surgically implanted heart valve substitutes | 2021 |
| 113 | ISO 5840-3 | Cardiovascular implants — Cardiac valve prostheses — Part 3: Heart valve substitutes implanted by transcatheter techniques | 2021 |
| 114 | ISO 14607 | Non-active surgical implants — Mammary implants — Specific requirements | 2024 |
| 115 | ISO 21534 | Non-active surgical implants — Joint replacement implants — Particular requirements | 2021 |
| 116 | ISO 21535 | Non-active surgical implants — Joint replacement implants — Specific requirements for hip-joint replacement implants | 2023 |
| 117 | ISO 21536 | Non-active surgical implants — Joint replacement implants — Specific requirements for knee-joint replacement implants | 2023 |
| 118 | ISO 25539-1 | Cardiovascular implants — Endovascular devices — Part 1: Endovascular prostheses | 2022 |
| 119 | ISO 25539-2 | Cardiovascular implants — Endovascular devices — Part 2: Vascular stents | 2020 |
| 120 | ISO 25539-3 | Cardiovascular implants — Endovascular devices — Part 3: Vena cava filters | 2024 |
| 121 | ISO 7198 | Cardiovascular implants and extracorporeal systems — Vascular prostheses — Tubular vascular grafts and vascular patches | 2016 |
| 122 | ISO 14708-1 | Implants for surgery — Active implantable medical devices — Part 1: General requirements for safety, marking and for information to be provided by the manufacturer | 2014 |
| 123 | ISO 14708-2 | Implants for surgery — Active implantable medical devices — Part 2: Cardiac pacemakers | 2025 |
| 124 | ISO 14708-3 | Implants for surgery — Active implantable medical devices — Part 3: Implantable neurostimulators | 2017 |
| 125 | ISO 14708-4 | Implants for surgery — Active implantable medical devices — Part 4: Implantable infusion pump systems | 2022 |
| 126 | ISO 14708-5 | Implants for surgery — Active implantable medical devices — Part 5: Circulatory support devices | 2020 |
| 127 | ISO 14708-6 | Implants for surgery — Active implantable medical devices — Part 6: Particular requirements for active implantable medical devices intended to treat tachyarrhythmia (including implantable defibrillators) | 2025 |
| 128 | ISO 14708-7 | Implants for surgery — Active implantable medical devices — Part 7: Particular requirements for cochlear and auditory brainstem implant systems | 2026 |
| Post-Market Surveillance & Vigilance Standards | |||
| 129 | ISO/TR 20416 | Medical devices — Post-market surveillance for manufacturers | 2020 |
| 130 | ISO/TS 5137 | Medical device maintenance management programme for healthcare delivery organizations (HDO) | 2026 |
| 131 | ISO/TR 18965 | Medical devices — Examples of the application of the risk management process to cardiac valve replacement and repair systems | 2025 |
| Cosmetic & Personal Care Product Standards | |||
| 132 | ISO 22716 | Cosmetics — Good Manufacturing Practices (GMP) — Guidelines on Good Manufacturing Practices | 2022 |
| 133 | ISO 24444 | Cosmetics — Sun protection test methods — In vivo determination of the sun protection factor (SPF) | 2019 |
| 134 | ISO 24442 | Cosmetics — Sun protection test methods — In vivo determination of sunscreen UVA protection | 2022 |
| 135 | ISO 23675 | Cosmetics — Sun protection test methods — In vitro determination of sun protection factor (SPF) | 2024 |
| 136 | ISO 23698 | Cosmetics — Measurement of the sunscreen efficacy by diffuse reflectance spectroscopy | 2024 |
| 137 | ISO 16128-1 | Cosmetics — Guidelines on technical definitions and criteria for natural and organic cosmetic ingredients — Part 1: Definitions for ingredients | 2016 |
| 138 | ISO 16128-2 | Cosmetics — Guidelines on technical definitions and criteria for natural and organic cosmetic ingredients — Part 2: Criteria for ingredients and products | 2017 |
How Satori One Click Solutions LLP Can Help
We support medical device manufacturers with:
- ISO 13485 QMS implementation & certification support
- ISO 14971 risk management file development
- ISO 10993 biological evaluation planning
- IEC 62304 software lifecycle documentation
- IEC 62366-1 usability engineering
- ISO 20417 labeling compliance
- Sterilization validation (ISO 11135, 11137, 17665)
- Cleanroom compliance (ISO 14644 series)
- Post - Market surveillance & vigilance (ISO/TR 20416)
- Regulatory submissions (FDA, CDSCO, TGA, Health Canada, EU MDR)
Contact us:
- 📧 satoriocs@gmail.com
- 📞 +91 9829098077 / +91 9216598077
- 🌐 satoriocs.com
